Abstract | Protein-protein complexes are prevalent in living systems and are central to the way biological processes function. Several of these complexes have been crystallized and their structures and functions characterized, while a much larger number of them (that may not crystallize) operate in the physiological system. Analyses of the known structures of proteinprotein complexes reveal that they form through interactions between specific patches on the surface of the component proteins. These patches, called interacting domains, are made from mostly non-contiguous residues in the protein sequence. Not all, but only a few of these residues called "hot spots", contribute significantly to the binding free energy of these complexes. Interactions between the hot spot residues from two interacting domains control the thermodynamics and oligomeric states of the complexes. The hot spot residues have been targets for the design of small molecule agonists with medicinal applications. The interaction domains in protein-protein complexes vary in their contour, size, shape, complementarity and affinity. The number of interacting protomers in a complex can vary from 2 to >30.
Introduction
Protein-protein interactions are central to most biological processes from cell multiplication to programmed cell death. 1, 2 An important requirement of molecular biology is the discovery of all proteins and protein-protein interactions as well as their biochemical and biological functions in organisms. 3, 4 An understanding of protein-protein complexes, their structural and functional characteristics [5] [6] [7] [8] and the forces that drive their intermolecular interactions is essential for the elucidation of molecular recognition in cells and its effects on biological processes. [9] [10] [11] [12] [13] [14] [15] [16] Proteins are molecular machines of the cell. Several proteins function in their monomeric form with remarkably high specificity and rates. The bovine pancreatic chymotrypsin (chymotrypsin) (PDB: 7GCH) is a classic example of such an enzyme. It is a serine protease, 17 which catalyzes the specific hydrolysis of peptide bonds that are adjacent to the aromatic amino acid residues, Tyr, Phe and Trp. A vacant cavity (cleft) near the active site of chymotrypsin interacts with the phenyl ring of the substrate peptide during catalysis ( Figure 1 ) and this interaction is crucial for its substrate specificity. The enzyme forms a transient covalently linked acyl-enzyme (ester) intermediate with the substrate, which enhances the rate of peptide bond hydrolysis 18 by a factor of at least 10 9 . A more fascinating aspect of proteins is that they can interact with each other and form stable multimeric assemblies, called protein-protein complexes. 19, 20 Cells have evolved to build these large, dynamic complexes from several monomeric proteins. The assembly of these complexes occurs in a controlled fashion, unlike in an aggregation process. 21, 22 Such protein-protein complexes can possess multiple active sites and hence have greater versatility of function in a single molecule, compared to monomeric proteins. Additionally, different oligomeric and conformational states of a protein-protein complex can each contribute to complementary or contradictory functions. 23 The stability of these states and the equilibrium between them are governed by their biophysical and biochemical environment in the cell. For example, AraC, a transcription regulator enzyme, forms two kinds of conformationally different complexes, depending on whether it is bound to arabinose or not (Figure 2 ). One of these complexes, the active form, promotes DNA transcription, and the other, the inactive form, represses it. 24 Owing to such functional versatility of protein-protein complexes, cells utilize them to not only catalyze complex reactions, but also to efficiently regulate them and do so selectively in response to stimuli or signal(s).
Various efforts over the past four decades have gone into the large scale analysis and understanding of the structures, functions and dynamism of protein-protein complexes, thus making possible the predictions of the properties of various novel proteins and their assemblies. [25] [26] [27] [28] [29] The identification of target-selective drugs and drug leads has also been facilitated. Progress in both these fields has been periodically reviewed individually. Aspects of the principles of interactions between proteins have also been discussed. [27] [28] [29] [30] [31] [32] [33] [34] Here we present an overview of the structure-function relationships in proteinprotein complexes along with the characteristics of the interaction domains between them.
A note about all the figures in this review is that, as in all other articles, structures from the Protein data Bank (PDB) are used to represent protein-protein complexes. Although biological macromolecules are dynamic, these structures provide good models for visualization. Most of the protein-protein complexes are shown in the molecular surface representation. Individual protomers are given different colors to clearly differentiate the boundaries of their surfaces and to highlight the interaction profile between the protomers. The molecular surface representation of protein complexes also helps to emphasize the fact that protein-protein interactions occur between the residues on the surface of the interacting protomers. The crystal structure of γ-chymotrypsin complexed with the trifluoromethylketone inhibitor Ac-Leu-Phe-CF 3 . The inset shows the interaction of the phenyl ring of Phe in the inhibitor with the cavity in chymotrypsin. odd number of subunits (protomers) are less frequently observed than even-numbered ones. While protein-protein dimer complexes are most prevalent among oligomers found in the PDB, complexes containing more than 30 individual protomer subunits 17 have also been characterized. In Escherichia coli, an average oligomeric state of four has been estimated for the proteins. 38 The quaternary architecture of these multimeric protein complexes represents one of the most intricate levels of molecular self-organization. Analyses of protein-protein complexes show that they exhibit large variations in their symmetry, size of the interacting domain and their molecular weight. 7, 11, [39] [40] [41] [42] [43] [44] [45] [46] The assembly of protomers in most homooligomeric complexes is symmetric. [42] [43] [44] [45] [46] [47] [48] Most homodimers (complexes containing two molecules of the same subunit) are C 2 symmetric; homotrimers predominantly exhibit C 3 symmetry; and most tetramers and hexamers exhibit dihedral symmetry. 7, 43 A few representative examples of lower and higher order oligomers containing 2 to 30 identical (homooligomer) or non-identical (heterooligomer) subunits in the complex are shown in Figure 3 .
Activities of Protein-Protein Complexes
Protein-protein complexes have evolved from monomeric forms 49 in order to acquire new abilities and functions. 39, 50 Unlike monomers, the functions of these complexes can be regulated and expressed Protein-Protein Complexes selectively in response to stimuli. [51] [52] [53] For example, adenosine-5´-monophosphate (AMP)-activated protein kinase (AMPK) is a heterotrimeric protein complex which has a key role in regulating cellular energy metabolism. 54 AMPK is an energy-sensing enzyme complex, which, in response to a fall in intracellular adenosine triphosphate (ATP) levels, activates energy-producing pathways and inhibits energy-consuming processes. 54 AMPK has been implicated in a number of diseases related to energy metabolism including type 2 diabetes, obesity and cancer. 55, 56 AMPK remains inactive and is converted to a catalytically competent form only upon the phosphorylation of an activation loop within the kinase domain ( Figure 5 ). The phosphorylation is, in turn, promoted by AMP binding to a c-regulatory domain. AMP binding also protects the enzyme against dephosphorylation. 57 Some enzymes are functional only in their oligomeric form. Rhodocetin 58 is a unique heterodimer purified from the crude venom of the Malayan pit viper, Calloselasma rhodostoma. It 
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Side view C7 -Symmetry consists of two protomers, the α-and β-subunits of 133 and 129 residues respectively. It inhibits collagen-induced aggregation and does so only when present as a dimer.
Another intelligent design is the multipleactive site complexes. The bovine trypsinBowman-Birk type inhibitor (BBI) 59 complex from soybean contains an assembly of cysteine-rich and highly cross-linked small proteins ( Figure 6 ). They function as specific pseudo substrates for the digestive proteinases like trypsin and chymotrypsin and inhibit their activities. 59 BBI contains two independent inhibitory binding sites, one for trypsin and the other for chymotrypsin and binds each protease to form a 1:1 complex, which augments its inhibitory activity towards them. Superoxide dismutase, 60 a dimeric enzyme complex, has an active site on each of its two subunits, which increases the number of productive collisions between enzyme and substrate and hence the rate of substrate transformation ( Figure 7) .
The active site of the E. coli aspartate transcarbamoylase dimer complex 61 is formed at the junction of the two interacting subunits which renders it with improved specificity through substrate channeling and assisted catalysis through subtle inter subunit motions (Figure 8 ).
Another important complex biological process, where nature has evolved an elaborately designed set of protein complexes for regulated activity, is in signal transduction. G-protein-coupled-receptors (GPCRs) are a type of membrane-spanning receptor proteins which receive various physiological signals like hormones and environmental signals such as heat and light and transmit them from the extracellular environment to the cell interior. 62 The GPCR complex consists of a seven transmembrane Aggregation: is the process where molecules of the same kind (e.g. proteins) preferentially interact with each other rather than with the solvent.
Protein-Protein Complexes
helix (7TM) scaffold with an extracellular receptor domain and a cytoplasmic receptor surface ( Figure 9) . 63, 64 The cytoplasmic receptor surface is bound to a heterotrimeric G protein complex (G αβγ ) containing a guanosine diphosphate (GDP)-bound G α subunit in its "silent" form. The binding of a signal, in the form of a hormone, to the extracellular receptor surface changes its conformation. This conformational change extends via the 7TM scaffold into the intracellular domain and catalyzes GDP→GTP (guanosine triphosphate) exchange in the G α subunit. 65 The GTP-bound G protein then decouples from the receptor and dissociates into a G α -GTP subunit and a G βγ dimer subunit. Both G α -GTP and G βγ subunits can elicit cell-specific responses via particular effector proteins and the regulation of intracellular second messenger levels. 62 The hydrolysis of GTP to GDP within G α results in the formation of G α -GDP which re-associates with the G βγ dimer, both of which recouple with the cytoplasmic receptor in the 7TM scaffold, hence completing the G protein cycle.
Apart from performing regulated functional roles, protein complexes such as microtubules 66 also take care of the transient or permanent structural needs in cells. Microtubules are a network of protein filaments that spatially organize the cytoplasm of eukaryotic cells. 67 These are tube like dynamic polymers of tubulin, which is a heterodimer of α-tubulin and β-tubulin associated with GTP ( Figure 10 ). GTP-bound tubulin tends to bind on to the so called (+) ends of tubulin and form protofilaments, which self-assemble into hollow microtubules. The hydrolysis of GTP to GDP through inter-domain contacts along the microtubule results in the destabilization and subsequent disassembly of the microtubule structure. 68 This dynamic behavior of microtubulin is coupled to chemical transitions in the adenosine triphosphatase (ATPase) cycle to effect the directed movement of proteins and other large molecular cargo along the microtubule surface, in and out of cells and organelles. 69 The microtubule self-assembly process also plays a major role in cell division. 70 These preceding examples exemplify the remarkable structures and regulated dynamism inherent in oligomeric protein complexes and highlight their superior functional versatility over monomeric enzymes.
Protein-Protein Interactions
In a typical protein complex, two or more protomers interact with each other through and along specific patches, called "interaction domains", on their surface. 71 A surface patch consists of a central surface accessible residue and its nearest surface accessible neighbors, comprising the C α and other atoms of these residues. The residues at the protein-protein interaction domains predominantly contain apolar aliphatic or aromatic side chains. Both polar and apolar side chain containing residues including glycine (Gly) are found at the center of these domains. 72 So far as is known, protein-protein interactions in oligomeric protein complexes result from interactions between residues that are exposed at, rather than buried inside, the surface of the component proteins. 73 Thus the physical connection between protein surfaces in oligomeric complexes is like a hand-shake or a hand-in glove model, where the interaction is between two surfaces ( Figure 12A ), rather than like a fork-in-spaghetti model, where atoms on the surface of a protein are in contact with those at the core of the protein partner. This is true in all protein-protein complexes studied, including domain swapping complexes.
The surface patch of the hen egg white lysozyme (PDB: 1FDL), complexed with the monoclonal antilysozyme antibody D1.3, is centered around a glycine (Gly 20). 72 Residues 18-27 and 117-125 are also surface-exposed and comprise two discontiguous patches, through which the hen egg white lysozyme makes hydrogen bonds and van der Waals interactions with the antibody (Figure 11 ). A few water molecules at the lysozyme (antigen)-antibody interface also mediate contacts between the antigen and the antibody. 74 Domain swapping complexes are an extreme possibility for protein-protein association where the interacting domain is made by the mutual exchange of an entire domain, like an α-helix or a β-sheet between each molecule of a dimer complex. 75 For example, in the dimer of bovine pancreatic ribonuclease (RNase A, PDB: 1A2W) 76 the N-terminal helix (residues 1-15) of each subunit is swapped into the major domain (residues 23-124) of the other subunit. The 3-stranded β-sheets of the two subunits are hydrogen bonded at their edges to form a continuous 6-stranded sheet across the dimer interface ( Figure 13 ). There is no insertion of any residues from a protomer through the sheet surface of the other subunit. The two subunits of the RNase A dimer are related by a rotation of approximately 160 degrees. 76 In the odorant-binding protein (OBP) homodimer complex from bovine nasal mucosa (PDB:1OBP), 77 the α-helix of each protomer stacks against the β-barrel of the other protomer ( Figure 14) .
The interacting domains in a protein-protein complex can also be appended through disulphide bonds. Bovine seminal ribonuclease 78 (PDB: 1BSR), is a dimeric enzyme in which the N-terminal segments of either monomer are interchanged so that each active site is formed by residues from both subunits. The two chains are related by a non-crystallographic two-fold symmetry and are covalently linked by two consecutive disulphide Figure 9 : A Schematic representation of the G-protein-coupled-receptor (GPCR) cyclic pathway. A) Extracellular agonist binding to the β2AR of the 7-transmembrane helix (7TM) scaffold (red), bound to the G-protein, G αβγ heterotrimer complex (PDB: 3SN6) at its cytosol end. The surface of G α is shown in green, G β in pink and G γ in dark blue. The inset shows GDP bound to G α a subunit of the G-protein heterotrimer complex. B) Receptor binding leads to conformational rearrangements at the cytoplasmic end of the 7TM segment and in the G-protein complex resulting in the exchange of GDP with GTP at the G α subunit. C) the GTP-bound Gα protomer dissociates from the G βγ complex anchored to 7TM. The inset shows GTP bound to the G α monomer. D) The GTP-bound G α monomer binds to the adenyl cyclase complex (PDB: 1AZS) and catalyzes the synthesis of cyclic AMP. E) The Dephosphorylation of GTP leads to a GDP-bound G α subunit which complexes with the free G βγ heterotrimer interface and completes the cycle. 
Formation of Protein-Protein Interfaces
An understanding of the physical nature of the interactions between protomers in proteinprotein complexes is crucial to comprehending their physical characteristics, the origin, control and the consequences in biological processes.
An interacting domain on a protein surface may preexist in the monomeric form of a protomer, or may get freshly exposed during or as a result of the formation of the protein complex. When residues of an interacting domain are already exposed on the protomer surface, possibly anchored by intrasubunit bonding, complexation with the protomer partner is straight forward. However, most surfaceexposed residues have few intramolecular contacts and are flexible. 21, 80 In these cases, the residue conformations are not preformed or fixed until dimerization occurs. 39 Alternatively, the residues on an interaction domain may remain unavailable for interaction (buried inside the protein) and only get freshly exposed prior to binding with the protomer partner. For example, actin is a 372-residue long protein which is composed of four subdomains: subdomain I (residues 1-32, 70-144, and 338-372), subdomain II (residues 33-69), subdomain III (residues 145-180 and 270-337), and B) The interacting domain on the surface of the hen egg white lysozyme comprising 9 residues (red patch) including the central Gly22 residue (blue). The inset shows Gly22 in a ball and stick representation (yellow) at the center of the interacting domain (red) on the surface of the hen egg white lysozyme (green). 
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subdomain IV (residues 181-269). 81 It is the major component of the thin filaments in muscle cells and of the cytoskeleton in non-muscle cells. 82 The residues H40-G48 of the actin subdomain II bind to DNase I (PDB: 1ATN). They are folded into an α-helix in the unbound conformation and a β-turn in the bound conformation ( Figure 16 ). This helix-to-turn conformational change in subdomain II of actin exposes new residues on its surface that form hydrogen bonds as an additional strand to the β-sheet in DNase I. 83 Interacting domains may form as a result of large conformational changes in one or either of the protomers upon complexation. 83 The LIR-1 protein is an immune receptor protein expressed on the surface of lymphoid and myeloid cells (PDB: 1P7Q). 84 LIR-1 contains two domains named D1 and D2 which are positioned at an interdomain angle of ≈85° in the unbound form of LIR-1. This angle changes 85 to 100° when LIR-1 forms a dimer complex with the protein HLA-A2 ( Figure 17) .
Modifications in the presentation of the same interacting domains in a dimer can be facilitated by their binding with allosteric modulators. 23 An excellent example involves the arabinose promoted modification of the dimer conformation and function in AraC. AraC is a transcription regulator in E. coli, which controls genes involved in the uptake and catabolism of the sugar arabinose. In the monomeric form, it has two domains, an arabinosebinding domain and a DNA-binding domain. When it dimerizes, the dimer has two arabinose and two DNA-binding domains. The two DNA-binding domains each bind to a different DNA site. With arabinose bound (PDB: 2ARC), AraC dimerizes such that the two DNA sites to which the protein attaches itself are distantly separated, creating a 210-base pair loop in the DNA and repressing the transcription of the promoters pBAD (the promoter for the arabinose operon) and pC. If the effector (arabinose) molecule is absent (PDB: 2ARA), the protein dimerizes along a completely different dimerization interface (interacting domain) and places the two DNA-binding domains close together (Figure 2 ). Now the dimer attaches itself to two adjacent DNA sites and promotes pBAD transcription instead of repressing it. 24 The interacting domains within the subunits of oligomers can undergo repeated modification by allosteric modulation of individual protomer subunits in proteins such as hemoglobin that exhibit positive cooperativity. The hemoglobin tetrameric complex has multiple substrate binding sites ( Figure 18 ). The quaternary structure of the oligomeric protein is such that it has an initial low affinity for the substrate. 86 However, as the ligand binds to one subunit of the oligomer, it introduces small changes in its local tertiary structure. As a result, the structural constraints of the quaternary oligomer complex relax, large changes occur in the quaternary structure, and the unliganded binding sites (active sites) exhibit increased ligand affinity. 87 On the other hand, simple changes in specific biophysical and biochemical conditions like the change in concentration of a modulator (like Ca 2+ Mg 2+ and Na + ) [88] [89] [90] can also prompt changes in dimerization interface and function. Evolution has utilized the unique ability of polypeptide chains to isomerize and adopt thermodynamically stable environment-dependent conformations to modify their interacting domains and regulate their recognitions and interactions with other cellular proteins.
Why Large Oligomeric Protein-Protein
Complexes? It is apparent from these examples that in various contexts, large protein-protein complexes are more beneficial to cells than are small proteins. The former can present a greater number of interacting domains (patches) on their surface than the latter. However, it is notable that evolution has chosen to build these large structures through multimeric associations of several small subunits instead of using single long high-molecular weight polypeptides. It has been proposed that this is because 1) assuming a constant probability of errors during protein expression (synthesis), a longer chain will have a greater chance of containing a deleterious error than a shorter one; 2) it is easier to selectively eliminate faulty subunits from multimeric complexes after several cycles of use; 3) the functional versatility of a protomer can be enhanced if it can function both as a monomer and as part of various multimeric complexes. 91 
Thermodynamics of Protein-Protein
Interactions The association of molecules to form higher ordered oligomers is in many respects, analogous to the block condensation model for protein folding where pre-folded subunits associate DNA: is deoxyribonucleic acid.
to form higher order structures. 92 Given the multitude of molecules that float around in the cell, however, the specific molecular recognition and association between folded monomers or their conformational isomers seems like a random event. Then how do biological processes such as signaling and inhibition which require error proof, and highly specific associations between protein molecules occur, even at extremely low physiological concentrations? This question can be addressed by understanding the thermodynamics of the protein-protein association reaction.
The Gibbs free energy (∆G observed ) of the association reaction between two monomeric proteins, in their stable solution conformations or in their isomerized forms, is dependent on their observed association constant K a at temperature T, as in the equation:
The kinetics of assembly of several proteins is analogous to bringing together two rigid objects. This means that in these cases, no intermediates are involved during the association of the subunits into a protein complex. However, as we saw in the examples of the preceding section, most association events are initiated by the change in conformation (i.e. the isomerization) of one or more of the interacting protomers. If the association process involves both the isomerization of the monomers and the formation of an intermediate structure before realizing the stable macromolecular quaternary complex, the theoretical association energy (∆G) will have contributions from three terms:
where ∆G interaction represents the interaction energy, ∆G isomerization the isomerization energy which accounts for the energy lost if the conformations of the free monomers are altered during complex formation, and ∆G rot,trans the energy lost in fixing one molecule relative to the other (Figure 19 ). In more accurate expressions, the energy required to solvate each of these forms, and to transfer the atoms from one form of each of the protomers to another, may also be included.
The interaction energy ∆G interaction results from the non-bonded interactions of both polar and apolar atoms at the protein-protein interface and is the driving force for the association process. This term has an enthalpic component due to van der Waals interactions, hydrogen bonds, and charged electrostatic interactions as well as an entropic component that results from the liberation of bound water molecules from the interface (the hydrophobic interactions). For molecules to associate and form a stable complex, the interaction energy (∆G interaction ) must be sufficiently large to overcome the two opposing energies (∆G isomerization and ∆G rot,trans ). 52 An important consequence of this feature is that not all proteins can associate with each other, because it is not always thermodynamically favorable. The interaction domains of proteins in complexes have evolved to have the optimum shape, size and topology such that their net energy of association is favorable only with their designated partners under suitable physiological conditions. Proteins that do not engage in proteinprotein interactions have surfaces that prevent them from accidently interacting with other proteins. Because of this structural feature, these proteins can exist at relatively high levels inside the cell. It may, however, be energetically feasible for an interacting domain to associate with more than one protein partner. Generally, the selectivity of interactions in such proteins is governed by the control of cellular expression of one of the protein partners. In complexes whose oligomeric states are regulated by binding with allosteric modulators, the binding event switches the protein between two conformational states, only one of which contains the interaction domain suitable for oligomerization. One may recall that in GPCRs a cascade of such conformational changes enable the (Figure 19 ). While the G α subunit is active in the GTP bound form, it becomes inactive upon the dephosphorylation of GTP to GDP (Figure 20) .
The thermodynamic picture discussed above is a simplification of the structural and biophysical determinants that lead to the formation of a protein-protein complex. The characterization of the complete set of determinants is more complex and will enable the elucidation of the intriguing processes that they influence and their evolutionary mechanisms in biological systems. Such understanding has already improved our ability to predict the functions of novel proteins and their reaction pathways in cells, and to design potential drugs.
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Protein-Protein Interaction Interfaces
Understanding the characteristics and function of a protein-protein complex requires a molecular analysis of the interacting domains of the proteins. These domains are termed as interfaces. Interfaces are optimal tight fitting 7, 52, 97 regions characterized by complementary pockets scattered throughout, with the central region being enriched in structurally conserved residues. 11, [98] [99] [100] [101] [102] Interfaces are defined based on the change in their solvent-accessible surface area (∆ ASA), calculated from a knowledge of the protomer structure 103 when going from a monomeric to an oligomeric state. The interface atoms are defined [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] as those whose ASAs decrease by > 1 Å 2 upon complexation. Since proteins interact through these interfaces, a number of their physico-chemical attributes like frequencies of atom-types, functional groups, amino acids, 53, 116 salt bridges, 117 hydrogen bonds 39 and hydrophobicity, 39 have been analyzed as possible determinants of the oligomer characteristics. 5, 7 Owing to the statistical nature of several of these analyses, 2, 5, 40 and due to the ambiguities inherent in the interpretations of the experimental methods 22, [118] [119] [120] [121] [122] [123] [124] employed, it is commonplace to generalize these characteristics. Such generalizations have served well to design algorithms for prediction 96, [125] [126] [127] [128] [129] [130] [131] [132] [133] of protein-protein interaction interfaces on protein surfaces. However, due to the complexity and uniqueness of each proteinprotein interaction interface, inferences made from such analyses must be treated with caution.
Protein-protein interaction interfaces are complex and can be characterized by their size, shape, electrostatic and hydrophobic interactions, 15, 116 surface complementarity 11 and flexibility of the protomers. Several reviews 5, 7, 39, 46, 114, 134, 135 have discussed these features and their significances in detail. The chief among these features is discussed here. The size of the protein interface is usually measured in terms of the total ∆ ASA for both molecules involved in the complexation event (going from a monomeric state to a dimeric state), and is expressed in area (Å 2 ) units. Since both the interacting protomer surfaces would contribute to approximately equal areas at the interface, the interface size is defined as half the total ∆ ASA. 11 In general the size of the interface area depends on the molecular weight of the interacting protomers and can vary from just a few hundred Å 2 (for example, the human TβR2 ectodomain-TGF-β3 complex, (for example, the actindeoxyribonuclease 1 complex, 81 PDB:1ATN- Figure 21 ). The size and the buried hydrophobic surface area have a direct correlation with the energy of the protein-protein interaction. The equilibrium between the inactive G αβγ G-protein heterotrimer complex containing the GDP-bound G α protomer and the catalytically active GTP-bound G α protomer. The forward reaction occurs when GTP exchanges with GDP at the binding site of the G α subunit. The reverse reaction occurs when GTP undergoes dephosphorylation to give a GDP-bound G α subunit. 
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rd of the interface surface comprises non-polar atoms. 39 The few conserved polar atoms at the binding interface form hydrogen bonds and counter the entropic cost on binding. 73 The surrounding residues generally provide a flexible cushion. On an average, there is about one hydrogen bond per 100-200 Å 2 of the interface surface. 39 The hydrogen bonds formed between side chain COOH of Glu27 of the C2 fragment of streptococcal protein G and the hydrogen bond donor atoms in Ser254 and Ile253 of the human immunoglobulin IgG (PDB: 1FCC) 114 are shown in Figure 22 . The electrostatic complementarity of interacting surfaces-in other words, the complementarity in shape and juxtaposition of the electrostatic surfaces-contributes to strong binding, rather than the complementary positioning of the hydrogen bonding groups or charges. This is important, since, unlike in the intramolecular backbone hydrogen bonds in proteins, the interface hydrogen bonding atoms are generally in non-ideal geometry, and hence the hydrogen bonds are usually weak in terms of energy. 117 However, hydrogen bonds and salt bridges directly influence the binding specificity, kinetics, lifetime and binding strength of complexes. 140 The His102 of barnase forms a strong electrostatic interaction with Asp39 of barstar and steers and rapid association (rate constant is 10 8 s
between the two proteins ( Figure 23 ). 142 It is to be noted that protein affinity and specificity are not necessarily coupled.
By combining X-ray crystallography with sitedirected mutagenesis, researchers have analyzed how protein-protein interfaces function. Through alanine scanning mutagenesis of proteins (where subsets of the protein surface are systematically mutated to alanine and the change in the binding free energy of the complex is studied) it is now understood that only a few of the residues at the interacting domain, termed "hot spots", make a significant contribution to the binding free energy of protein-protein complexes. 141, 143, 144 A residue is defined as a hot spot if there is a significant binding free energy change (∆∆G ≥ 4 kcal/mol) when it is mutated to alanine. 12, 114, 145 However, in order to map all the residues that contribute to the binding free energy of a protein-protein complex, a lower cut off of ∆∆G ≥ 2 kcal/mol is generally used during the analysis and identification 128, 143, 146 of potential hot spot residues in protein complexes.
Hot spots are found on either side of the interacting interface. Usually, hot spot residues from two interacting domains form tightly packed pairs, and can be involved in intermolecular hydrogen bonds ( Figure 22 ).
Systematic analyses of hot spots have shown that tryptophan, arginine and tyrosine (in that order) are the fundamental (most conserved) hot spot amino acids. 147 The aromatic residues are understood to contribute through hydrogen bonding (tryptophan is a donor and tyrosine can be both a donor and an acceptor), and the protection of fragile hydrogen bonds from water and π-π interactions. Tryptophan is the most frequently observed hot spot residue due to its large flat aromatic surface. In the growth hormone-growth hormone binding protein complex, there are 29 interfacial residues, out of which four are hot spots. 12, 148 Two of these hot spots are tryptophan (∆∆G = 4.5 kcal/mol). Tyrosine is a more frequently observed hot spot residue than phenylalanine due to its hydrogen-bonding ability. Arginine can participate in a hydrogen-bonding network with upto five hydrogen bond donors and a salt bridge through the positive charge on the guanidinium group. Aspartate and aspargine are favored over glutamate and glutamine, presumably due to differences in side-chain conformational entropy. Isoleucine is more than 10 times as frequently seen as a hot spot as leucine. Serine, leucine (not isoleucine) and valine seldom function as hot spots. 12 Owing to the large impact of the hot spot residues on the binding free energy of complexes, they are protected from the bulk solvent by the surrounding residues. A Few common characteristics are discerned for these surrounding residues (See Figures 24 and 25 for examples of hot spots). Their hydrophobicity, shape, charge and interfacial residue type inadequately explain or predict the high energy hot spots. 149 Most protein-protein interfaces, especially those in homodimers, are complementary to each other. Complementarity is conferred by the careful structuring of interfaces between interacting domains that allows strong interactions between protein pairs (like hot spots) while minimizing the strength of unwanted interactions. 125 Either both the interacting surfaces are found to be planar (Figure 26 ) as in the serratia endonuclease dimer (PDB: 1SMN) with 4 salt bridges and several hydrogen bonds and nonpolar interactions in the interface, 150 or one of them contains a crevice or a pocket into which a residue or a whole secondary structural domain from the other protomer protrudes. 151 All types of secondary structures (helices, α-sheets, turns and random coil) have been found in the contact areas of 153 and loop (bovine pancreatic α-chymotrypsin and the third domain of the Kazal-type ovomucoid from Turkey (OMTKY3), PDB: 1CHO), 101 at the interfaces are shown in Figure 27 . In the subtilisin Carlsberg-eglin C complex (1 CSE), 154 an elastase inhibitor with a protrusion interface, most of the intermolecular contacts are contributed by nine residues (Gly40-Arg48) in a loop (Figure 28 ). The complex (PDB: 1I99) between the serine protease inhibitor (Michaelisserpin) and trypsin shows a 20 residue loop that protrudes from the serpin molecule and interacts with a rather large concave region in trypsin (Figure 29 ). 155 
Classification
Protein complexes have been so termed based on the number and identities of the protomers and the interfaces that form the interaction. Oligomers of the same protomer are called homooligomers. Oligomers containing non-identical polypeptide chains are called heterooligomers. 156 When a protomer of an oligomeric complex is not found as a stable structure on its own in vivo, the complex is called obligate. When a protomer is active only in its oligomeric form, then it is said to be functionally obligate. The Arc repressor is an obligate dimer ( Figure 2 ) whose dimeric structure is essential for DNA-binding. 157 When the protomers of an oligomeric complex can exist as stable structures, the complex is called non-obligate. The RNase A dimer is a homodimeric non-obligate protein complex 158 ( Figure 13 ). Many known hetero-oligomeric protein complexes, like the RhoA-RhoGAP dimer, 159 ( Figure 30 ) involve non-obligate interactions of protomers that exist independently. 2 When the association of monomers in an oligomeric complex involves an association between the same interaction domains on each subunit, it is called an isologous association. Most isologous oligomers exhibit circular symmetry. Arc repressor and lysin dimer complexes are isologous and are complexed in a C 2 symmetric fashion. When different interfaces are involved in the individual monomers of a complex, it is called a heterologous association. Protein-protein interactions can also be vaguely distinguished based on the lifetime of the complex. A permanent complex is stable and exists primarily in the complexed form. A transient complex associates and dissociates in vivo. 5 The dynamic equilibrium of transient complexes is controlled by molecular or biophysical triggers. Transient complexes play a key role in almost all regulatory activities, signal transductions and metabolic processes. 
Protein-Protein Interaction Inhibitors
Protein-protein complexes are ubiquitous and are central to the activities of biological systems. It has long been realized that small molecule antagonists that disrupt complex formation can have potential as drugs. 160 Small molecules that competitively bind directly and strongly to hot spots of protein-protein interfaces constitute a class of drugs with potential for high selectivity. These molecules are generally flat, owing to the flat nature of their target interface. Several highly selective human therapeutics have been designed. For example, the flat molecule ligands 1 and 2 ( Figure 31 ) bind at the hot spot of B7-1, an important T-cell activation modulator and efficiently inhibit its binding with the protein CD28. 161, 162 Natural small molecule substrates of complex enzymes have traditionally served as lead templates for designing such antagonists. These molecules map the epitope of the binding site. The design of the small-molecule inhibitors, 3 and 4, [163] [164] [165] of interleukin-2 comes under this category. Alternatively, peptide based epitope mimics are also known, such as the constrained peptidomimic that reproduces the bioactive helical face of the 16 residue helical domain of the BAK regulator protein that binds to the interaction domain of BCL-xL, an antiapoptotic protein ( Figure 32 ). 166 Molecules that bind allosteric sites on proteinprotein complexes or their protomers form another class of potential drugs. These drugs are effective in inhibiting large conformational changes that are at the origin of protein-protein complex formation. LFA1 is an extracellular protein (integrin family) whose activity is regulated by metal ions outside the cell and signaling pathways inside the cell. By binding other cell-surface molecules called cell-adhesion molecules, LFA1 mediates cell-cell adhesion, extravasation and T-cell activation. Small molecule 5 167, 168 binds in the hydrophobic pocket in the I-domain of LFA1 ( Figure 33 ) and allosterically disorients its interface topology, hence inhibiting its activity. Epitope: is the surface patch on an antigen molecule, which is recognized for binding by molecules of the immune system, like antibodies and T cells.
Protein-Protein Complexes
Conclusions
The number of protein-protein complexes in biological systems is much larger than what has been characterized. Patterns have, however, emerged from structural, biophysical and statistical analyses of the known complexes. These complexes have evolved to perform multifarious activities that are not possible by monomeric proteins. Proteins interact along their surfaces to form proteinprotein complexes. The interacting domains vary in their contour, complementarity and affinity. A few key residues on small patches on the surface of interacting proteins seem to greatly influence the thermodynamics and the interaction characteristics of protein-protein complexes. These residues have been prime targets for drug design and therapeutics. Advances in genomics and proteomics will further refine our understanding of protein-protein complexes and their biological functions. 
